Breakthrough Behavioral-Science Technology Powers High-Performance TV, Podcast, and Digital Campaigns
Los Angeles, CA , Nov. 26, 2025 (GLOBE NEWSWIRE) -- ADcology, the…
Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate
Antibody levels remained well above baseline across all six serotypes and age…
Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference
Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference…
Standards + Excelerate Copilots from Standards Core Now Available in the Microsoft Marketplace
HOUSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Standards Core LLC today announced…
DHL boosts operational efficiency and customer communications with HappyRobots AI Agents
San Francisco, Nov. 25, 2025 (GLOBE NEWSWIRE) -- DHL Group, the world’s…
Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS
Positive results from ianalumab pivotal Phase III trial in ITP patients previously…
Press Release: Sanofi and Regenerons Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the…
Memory Lift Launches Revolutionary Brain Booster: The Truth About the Memory Lift Nootropics Supplement
New York City, NY, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Â Memory Lift…
Surgent CPE Launches First-of-Its-Kind Agentic AI CPE Series for Accounting and Finance Professionals
RADNOR, Pa., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Surgent CPE, a division…
Rakovina Therapeutics Showcases Compelling Preclinical Data on AI-Discovered CNS-Penetrant ATR/mTOR Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting
VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc.…